Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2025.368 | Retention rate of adalimumab bio-original and biosimilars in rheumatic diseases: a real-world study from the Hong Kong Biologics Registry |
Dr. TAM Lydia Ho Pui 譚皓珮 |
| 2025.369 | Retention rate of adalimumab bio-original and biosimilars in rheumatic diseases: a real-world study from the Hong Kong Biologics Registry |
Dr. HO Ling Yin 何令妍 |
| 2025.373 | A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer | Prof. YEO Winnie |
| 2025.381 | A multicenter study on the clinicopathological and genetic features of myeloid neoplasms with isochromosome 17q | Dr. Cheung Joyce Sin |
| 2025.363 | Epidemiological analytics in the realm of big data for the enhancement of the understanding of orthopaedic conditions | Prof. LUI Pauline Po Yee |
| 2025.361 | Medication adherence patterns and treatment beliefs of patients using proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) | Dr. TSANG Chiu Chi |
| 2025.360 | Establishment of New Territories East Cluster Biliary Tract Cancer Database | Prof. CHAN Stephen Lam |
| 2025.346 | The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients |
Dr. Tang Hoi San 鄧凱珊 |
| 2025.345 | The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients |
Prof So Ho 蘇皓 |
| 2025.344 | The 2023 ACR/ EULAR Classification Criteria for the thromboembolic antiphospholipid syndrome: a validation study in Hong Kong Chinese patients |
Dr Ho Ling Yin 何令妍 |
| 2025.348 | Understanding Mental Health Screening for Caregivers of Children with Developmental Concerns: Perspectives and Barriers Among Caregivers and Healthcare Providers Across Global Contexts | Dr. WONG Wing Ho |
| 2025.349 | Spatial multi-omics analysis of tumor-infiltrating regulatory B cells in ovarian cancer with lymphotoxin overexpression in ovarian cancer typing diagnosis and recurrence prediction |
Prof. WANG Ronald 黃志超 |
| 2025.339 | Lung Cancer Biomarker: Methylation Risk Score for Early Detection and Minimal Residual Disease Monitoring | Dr. LI Siu Ching |
| 2025.338 | Development of a Neurofeedback System to Support Emotion Visualization | Dr. WANG Yang |
| 2025.337 | Primary Obesity Surgery Endoluminal 2.0 (POSE-2) Procedure for Treatment of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease |
Dr. NG STEPHEN KA KEI 吳家琦 |
| 2025.320 | Radiation-free Assessment of Skeletal Maturity and Bone Health Status in Paediatric Spinal Deformity | Dr. LAU Adam Yiu Chung |
| 2025.321 | Organoids derived from EUS-guided tissue sampling for precision oncology in advanced pancreatic ductal adenocarcinoma | Dr. XIA Xianfeng |
| 2025.336 | Validation of the Hong Kong Database of Emotional Face (HKDEF) | Dr. WONG Wing Ho |
| 2025.350 | The Development of an Intelligent System for Real-time Automated Anatomical Recognition System During Endoscopic Ultrasound | Prof. CHAN Shannon |
| 2025.324 | Establishment of Hong Kong Diabesity Register and a 3-year Randomized Clinical Trial for the Investigation of the Effectiveness of a Multicomponent Integrated Care Program in Chinese with Diabesity | Prof. KONG Alice Pik Shan |
| 2025.319 | App-assisted implementation of evidence-based management of acute intracerebral haemorrhage |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2025.356 | Development for AI-Powered Nasal Cavity Reconstruction | Prof. TONG Michael C.F. |
| 2025.351 | Long-term effects and healthcare costs of extreme heat on cardiovascular complications in Chinese patients with type 2 diabetes | Dr. LAU Siu Him |
| 2025.316 | Can biologic DMARD use retard syndesmophytes and facet joint arthritis progression and resolve axial inflammatory in psoriatic arthritis? A prospective follow up study using low-dose computed tomography and magnetic resonance imaging | Prof. TAM Lai Shan |
| 2025.352 | Review of hip fracture patients with history of fragility fracture | Dr. FUNG Kwun Ping |
| 2025.358 | Investigating the Predictive Power of Coronary Plaque for Major Adverse Cardiovascular Events (MACE) in Psoriatic Arthritis: A 10-year Retrospective Study | Prof. TAM Lai Shan |
| 2025.335 | Butyrate and Taurine to reduce chronic postsurgical pain in adult cardiac surgical patients: a Bayesian Optimized double-blinded randomized controlled trial | Dr. WONG Man Kin |
| 2025.331 | Effectiveness of a Game-based educational workshop on Hong Kong students’ change in self-efficacy, awareness, and attitudes to drug abuse | Prof. LI William Ho Cheung |
| 2025.353 | An in-vitro study to examine the activity of Avibactam-aztreonam against Carbapenem resistant gram-negative bacilli in a tertiary referral laboratory in Hong Kong | Dr. LAI Christopher Koon Chi |
| 2025.330 | Effectiveness of Virtual Reality-enhanced Interventions on Preoperative Anxiety in Adults Undergoing Elective Surgery: A 3-arm randomised controlled trial (VIPA trial) | Mr. CHAN Sin Lun |
| 2025.359 | A two-part phase 1 open-label safety and pharmacokinetic study of intravenous RC220 in combination with doxorubicin in adult patients with solid tumours | Dr. LOONG Herbert Ho Fung |
| 2025.304 | Voice Link 2.0 AI Speech Recognition Investigation | Dr. FONG Raymond |
| 2025.303 | Voice Link 2.0 AI Speech Recognition Investigation | Dr. CHAN Edwin Ho Yin |
| 2025.355 | Retrospective Study Protocol – Data collection for AutoTV and AutoView |
Prof. LEE Alex Pui Wai 李沛威 |
| 2025.322 | Development and validation of a new scale to assess sexual problems in people with prostate cancer and to design an electronic patient-reported outcome measure for this population (ePROM-SexPCare) | Prof. NG Chi Fai |
| 2025.329 | The effects of theory-guided multimodal educational (TIME) programme on the faecal occult blood test (FOBT) uptake rates among adults at average-risk of colorectal cancer: A randomized controlled trial | Ms. KWAN Siu Kuen |
| 2025.310 | Systemic absorption of oral vancomycin: prevalence, risk factors, and clinical implications |
Prof. SZETO Cheuk Chun Cheuk Chun Szeto |
| 2025.315 | The Chinese University of Hong Kong Myasthenia Gravis Registry (CUHKMGR) | Dr. CHOI Joseph Chun Ho |
| 2025.311 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2025.305 | Retrospective Review on the Management of Diabetic Ketoacidosis in the Intensive Care Unit | Dr. HO Lap Tin |
| 2025.323 | Pilot Study on Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer | Prof. TEOH Jeremy Yuen Chun |
| 2025.309 | A portable “sample to answer” microfluidic system for rapid detection of bacterial pathogens using nucleic acid analysis | Prof. LING Lowell |
| 2025.314 | Psychological Distress and its Predictive Factors among Parents of Sick Children | Dr. HO Long Kwan |
| 2025.317 | Effectiveness of a Mindfulness-Oriented Respiratory Distress Symptom Intervention for Patients with Lung Cancer and Its Association with Brain Activity Changes | Dr. LOONG Herbert Ho Fung |
| 2025.343 | Development for AI-Powered Retrograde Intrarenal Surgery | Prof. NG Chi Fai |
| 2025.308 | A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in combination with Durvalumab, Carboplatin and Etoposide versus Durvalumab, Carboplatin and Etoposide in Untreated Extensive Stage Small-Cell Lung Cancer (DeLLphi-312) | Dr. LOONG Herbert Ho Fung |
| 2025.307 | ASKHER2-China: Perceptions, attitudes, and behaviors towards the risk of disease recurrence among women with early-stage HER2+ breast cancer in mainland China and Hong Kong | Prof. YEO Winnie |
| 2025.328 | Effect of A Remote Counselling Programme on Screening Uptake in First-Degree Relatives of Colorectal Cancer Patients: A Randomised Controlled Trial |
Ms DONG Bei 董贝 |
| 2025.306 | A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma | Prof. CHAN Stephen Lam |
| 2025.327 | Effectiveness of mHealth-based survivorship programme on health-related quality of life among Vietnamese colorectal cancer survivors: A randomised controlled trial | Ms. Pham Nhat Vi Do |
Page 2 of 267.